指南与共识慢性肾脏病

肾脏相关研究优先事项:推进肾脏照护的议程——美国国家肾脏基金会立场声明

Research Priorities for Kidney-Related Research-An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation.
指南 / 共识 · Am J Kidney Dis · 2021-10-07

尽管慢性肾脏病(CKD)在美国患病率高且经济负担重,但美国国立糖尿病、消化和肾脏疾病研究所(NIDDK)对肾脏相关研究、预防和教育活动的联邦资助仍显著低于其他慢性病。2021年美国国家肾脏基金会(NKF)召开两次研究圆桌会议(临床前和临床研究),汇集肾病学领袖、相关研究机构、CKD患者及照护者和肾脏捐赠者,旨在确定临床前和临床肾脏相关研究的优先事项。本立场声明提出的研究优先事项包括4个临床前科学主题和3个临床科学主题,若获额外联邦资助,将增进对多样人群肾脏病发生发展的理解、吸引产业投资并带来新的个性化治疗。

要点

  • 肾脏研究联邦资助显著低于其他慢性病,需增加支持。
  • 圆桌会议确定4个临床前和3个临床科学主题的研究优先事项。
  • 优先事项有望在未来5-10年惠及肾脏病患者。

核心结论

  • 肾脏相关研究优先事项若获额外联邦资助,将增进对肾脏病发生发展的理解、吸引产业投资并带来新的个性化治疗。

研究设计与样本

  • 2021年美国国家肾脏基金会(NKF)召开两次研究圆桌会议(临床前和临床研究),汇集美国知名学术机构和制药行业的肾病学领袖、研究专家以及CKD患者、照护者和肾脏捐赠者。

主要发现

  • 研究优先事项分为4个临床前科学主题:扩展数据科学能力、定义肾脏病机制并利用遗传工具识别新治疗靶点、开发更好的人类疾病模型、测试细胞特异性药物递送系统并利用基因编辑。
  • 研究优先事项还包括3个临床科学主题:扩大临床试验数量和包容性、开发和测试减少健康差异的干预措施、支持实施科学。

临床怎么用

  • 肾脏病学界可依据这些优先事项争取联邦资助和产业投资,推动未来5-10年的创新研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the high prevalence and economic burden of chronic kidney disease (CKD) in the United States, federal funding for kidney-related research, prevention, and education activities under the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) remains substantially lower compared to other chronic diseases. More federal support is needed to promote critical research that will expand knowledge of kidney health and disease, develop new and effective therapies, and reduce health disparities. In 2021, the National Kidney Foundation (NKF) convened 2 Research Roundtables (preclinical and clinical research), comprising nephrology leaders from prominent US academic institutions and the pharmaceutical industry, key bodies with expertise in research, and including individuals with CKD and their caregivers and kidney donors. The goal of these roundtables was to identify priorities for preclinical and clinical kidney-related research. The research priorities identified by the Research Roundtables and presented in this position statement outline attainable opportunities for groundbreaking and critically needed innovations that will benefit patients with kidney disease in the next 5-10 years. Research priorities fall within 4 preclinical science themes (expand data science capability, define kidney disease mechanisms and utilize genetic tools to identify new therapeutic targets, develop better models of human disease, and test cell-specific drug delivery systems and utilize gene editing) and 3 clinical science themes (expand number and inclusivity of clinical trials, develop and test interventions to reduce health disparities, and support implementation science). These priorities in kidney-related research, if supported by additional funding by federal agencies, will increase our understanding of the development and progression of kidney disease among diverse populations, attract additional industry investment, and lead to new and more personalized treatments.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Research Priorities for Kidney-Related Research-An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation. Am J Kidney Dis. 2021. PMID: 34627932. doi:10.1053/j.ajkd.2021.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。